Where diagnosis for myelodysplastic neoplasms (MDS) stands today and where it will go: The role of flow cytometry in evaluation of MDS

被引：2
|
作者：
Wang, Wei [1 ]
Khoury, Joseph D. [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[2] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
来源：
CYTOMETRY PART B-CLINICAL CYTOMETRY | 2023年 / 104卷 / 01期
关键词：
D O I：
10.1002/cyto.b.22110
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：12 / 14
页数：3
相关论文
共 50 条
  • [31] Idiopathic cytopenia of undetermined significance (ICUS):: Impact of flow cytometry immunophenotyping (FCI) in the diagnosis of myelodysplastic syndrome (MDS) when morphology is not conclusive.
    Font, Patricia
    Subira, Dolores
    Loscertales, Javier
    Arranz, Eva
    Alonso, Arancha
    Perez-Saenz, M. Angeles
    Escudero, Antonio
    Fernandez-Ranada, Jose Maria
    Vallespi, Teresa
    BLOOD, 2007, 110 (11) : 728A - 728A
  • [32] Utility of Flow Cytometry (FC) in the Assessment of Therapeutic Efficacy in Myelodysplastic Syndromes (MDS) After Therapeutic Intervention.
    Burbury, Kate
    Gambell, Peter
    Came, Neil
    Lynch, Kevin
    Seymour, John F.
    Prince, Miles
    Westerman, David A.
    BLOOD, 2009, 114 (22) : 1082 - 1082
  • [33] Flow cytometry in myelodysplastic syndromes:: a new tool in the classification and prognostification of low/int-l risk MDS
    van de Loosdrecht, A. A.
    Westers, T. M.
    Westra, A. H.
    Drager, A. M.
    van der Velden, V. H. J.
    Ossenkoppele, G. J.
    LEUKEMIA RESEARCH, 2007, 31 : S86 - S87
  • [34] Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: Report from the Dutch Working Party on Flow Cytometry in MDS
    Westers, Theresia M.
    van der Velden, Vincent H. J.
    Alhan, Canan
    Bekkema, Roelof
    Bijkerk, Andre
    Brooimans, Rik A.
    Cali, Claudia
    Drager, Angelika M.
    de Haas, Valerie
    Homburg, Christa
    de Jong, Anja
    Kuiper-Kramer, P. A.
    Leenders, Marije
    Lommerse, Ingrid
    Marvelde, Jeroen G. te
    van der Molen-Sinke, Joke K.
    Moshaver, Bijan
    Mulder, Andre B.
    Preijers, Frank W. M. B.
    Schindhelm, Roger K.
    van der Sluijs, Alita
    van Wering, Elisabeth R.
    Westra, August H.
    van de Loosdrecht, Arjan A.
    LEUKEMIA RESEARCH, 2012, 36 (04) : 422 - 430
  • [35] Flow cytometry in myelodysplastic syndromes:: A new tool in the classification and prognostification of low/int-I risk MDS
    van de Loosdrecht, A. A.
    Westers, T. M.
    Westra, A. H.
    Drager, A. M.
    van der Velden, V. H. J.
    Ossenkoppele, G. J.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2008, 74B (01) : 59 - 59
  • [36] Developing a flow cytometric maturation/differentiation index of the bone marrow for the diagnosis of myelodysplastic syndromes (MDS)
    Verigou, E.
    Smyrni, N.
    Kolliopoulou, G.
    Hala, E.
    Lampropoulou, P.
    Theodorou, G.
    Kalogianni, F.
    Zikos, P.
    Starakis, I.
    Solomou, E.
    Karakantza, M.
    Symeonidis, A.
    LEUKEMIA RESEARCH, 2013, 37 : S51 - S52
  • [37] Use of a Blast Dominance-Hematogone Index for the Flow Cytometric Evaluation of Myelodysplastic Syndrome (MDS)
    Schenkel, Jason M.
    Hergott, Christopher B.
    Dudley, Graham
    Drew, Mai
    Charest, Karry
    Dorfman, David M.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 151 (06) : 584 - 592
  • [38] Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS
    A Porwit
    A A van de Loosdrecht
    P Bettelheim
    L Eidenschink Brodersen
    K Burbury
    E Cremers
    M G Della Porta
    R Ireland
    U Johansson
    S Matarraz
    K Ogata
    A Orfao
    F Preijers
    K Psarra
    D Subirá
    P Valent
    V H J van der Velden
    D Wells
    T M Westers
    W Kern
    M C Béné
    Leukemia, 2014, 28 : 1793 - 1798
  • [39] Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group
    Loosdrecht, Arjan A.
    Kern, Wolfgang
    Porwit, Anna
    Valent, Peter
    Kordasti, Sharham
    Cremers, Eline
    Alhan, Canan
    Duetz, Carolien
    Dunlop, Alan
    Hobo, Willemijn
    Preijers, Frank
    Wagner-Ballon, Orianne
    Chapuis, Nicolas
    Fontenay, Michaela
    Bettelheim, Peter
    Eidenschink-Brodersen, Lisa
    Font, Patricia
    Johansson, Ulrika
    Loken, Michael R.
    Marvelde, Jeroen G.
    Matarraz, Sergio
    Ogata, Kiyoyuki
    Oelschlaegel, Uta
    Orfao, Alberto
    Psarra, Katherina
    Subira, Dolores
    Wells, Denise A.
    Bene, Marie C.
    Della Porta, Matteo G.
    Burbury, Kate
    Bellos, Frauke
    van der Velden, Vincent H. J.
    Westers, Theresia M.
    Saft, Leonie
    Ireland, Robin
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2023, 104 (01) : 77 - 86
  • [40] IMPLEMENTATION OF DIAGNOSTIC FLOW CYTOMETRY ALLOWS FOR THE DISSECTION OF AGE RELATED LOSS OF Y CHROMOSOME FROM MYELODYSPLASTIC SYNDROME (MDS)
    Oelschlaegel, U.
    Mohr, B.
    Sockel, K.
    Ehninger, G.
    Bornhaeuser, M.
    Platzbecker, U.
    LEUKEMIA RESEARCH, 2017, 55 : S98 - S98
12345